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Background. Polycystic ovarian syndrome (PCOS) is a multifaceted disorder characterized by varying clinical presentations.
Objective. The aim of this study was to determine urban and rural differences in the burden of polycystic ovarian syndrome
among Indian adolescent females aged 12 to 19 years. Methods. A pilot cross-sectional study was conducted for a period of one
month (August-September 2013) at Balaji Hospital, Vellore, Tamil Nadu, India. The final sample included 126 study participants
located in various urban (50%, 𝑛 = 63) and rural (50%, 𝑛 = 63) settings. Information was gathered on sociodemographic and
anthropometric characteristics, clinical history, occurrence of acne andhirsutism, serum testosterone levels, obstetric history, family
history of chronic diseases, menstrual history, physical activity, and dietary intake. Results. Eighteen percent of the participants
were confirmed of having PCOS by recent guidelines of Rotterdam Consensus for adolescent diagnosis of PCOS (presence of all
three elements). Majority of the individuals with PCOS had an average age of 16 (SD = 2) (𝑃 = .02) years with an average age of
menarche 12 years (SD = 1).Conclusion.The proportion of participants diagnosed with PCOSwas higher among urban participants
in comparison to rural participants.
1. Introduction
Polycystic ovarian syndrome (PCOS) has been defined by
the National Institute of Health and Rotterdam criteria as a
hormonal disorder characterized by the presence of at least
one polycystic ovary (presence of multiple cysts) accom-
panied by ovulatory dysfunction and excessive secretion of
androgens [1]. Consensus on women health aspect of PCOS
has suggested different criteria for diagnosis of PCOS in
adolescents from those used for adults. According to its
suggestions PCOS in adolescent should include all the three
elements of Rotterdam criteria in which oligomenorrhea
should be present after two years of menarche or primary
amenorrhea at the age 16 years; polycystic ovaries on ultra-
sound along with ovarian size of more than 10 cm3 and
hyperandrogenemia should be present [2]. The occurrence
of polycystic ovarian syndrome has been associated with
an increased risk for Type 2 diabetes, gestational diabetes,
hypertension, and gynecological cancers [1, 3]. Studies have
reported 10 times greater risk of developing Type 2 diabetes
in women affected by PCOS [4].Theworldwide prevalence of
polycystic ovarian syndrome ranges from 2.2 to 26% [4]. The
rates of polycystic ovarian syndrome have been reportedly
high among Indian women compared to their Caucasian
counterparts [5], with an estimated prevalence of 9.13% in
Indian adolescents [4, 6].
Clinical presentations of polycystic ovarian syndrome
include abnormal facial and skin hair growth (hirsutism),
acne, and irregular, or absence of, menstrual periods [7].
However acne is most common during adolescent phase
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of life and there is limited literature on adolescent andro-
genic alopecia [2]. Differential diagnosis of PCOS includes
congenital adrenal hyperplasia (late onset) hyperthecosis,
Cushing syndrome, hyperprolactinemia, hypothyroidism,
and ovarian and adrenal androgen secreting tumors [2].
Different categories in the clinical presentations of PCOS
have been distinguished according to the Rotterdam criteria
[7]. They include (i) “classic PCOS” characterized by the
presence or absence of ovarian cysts with excessive androgen
secretion and irregular menstrual periods, (ii) “ovulatory
PCOS” characterized by the presence of increased androgen
secretion andmultiple cysts, and (iii) “nonandrogenic PCOS”
associatedwith irregularmenstruation andmultiple cysts [7].
The determinants of polycystic ovarian syndrome have
been linked to both hereditary and environmental factors [1].
The attributed hereditary factors include early age of sexual
maturation, premature fetal development, and family history
of PCOS among first-degree relatives [1, 8]. Studies have
reported an earlier age at diagnosis of PCOS (9–12 years)
among adolescent females with earlier maturation of sexual
characteristics compared to their later counterparts (13–18
years) [8]. This has been attributed to an increased androgen
secretion associated with early onset of puberty [1]. It has
been reported that premature fetal development leads to an
earlier andmore rapid onset of puberty with an increased risk
of developing PCOS [9]. Clinical manifestations of associated
symptoms such as hyperinsulinemia have also been observed
in offspring of PCOS affected women long before the onset of
puberty affirming the role of family history [9].
The associated environmental factors reported include
physical inactivity, obesity, and its associated insulin resis-
tance [7]. Insulin resistance which is of high prevalence in
the Indian population [7] has been consistently reported
as a strong determining factor for the occurrence of PCOS
in Indian adults and adolescents [1]. While several studies
have reported an association between excessive androgen
secretion and the occurrence of insulin resistance in affected
women, temporality has not been established [1]. There are
marked variations in the prevalence of insulin resistance
across different geographical regions of India and among
urban and rural settings [10]. A higher prevalence of insulin
resistance has been observed in urban Indian populations
compared to their rural counterparts [10]. This is suggestive
that a marked difference could exist in the prevalence of
PCOS among different settings.
Since the clinical manifestations of PCOS have been
consistently observed in early adolescence, the increased risk
of developingType 2 diabetes and its associated comorbidities
during later years can be controlled by identifying high
risk populations and implementing preventive measures.
However, the nature of the environmental and lifestyle
determinants of PCOS including physical activity and obesity
is suggestive of the fact that variations could exist in the
prevalence of PCOS in urban and rural settings due to
dissimilar dietary practices and the level of physical activity.
Although studies have reported the prevalence of PCOS in
Indian adolescents, no studies have examined the differences
in prevalence rates in urban and rural settings. We hypoth-
esize that the burden of PCOS will be considerably lower
among rural Indian adolescents compared to their urban
counterparts. Such results could foster the implementation
of lifestyle preventive measures for PCOS and its associated
comorbidities in different settings at an earlier stage. The
aim of this study was to determine urban rural differences
in the burden of polycystic ovarian syndrome among Indian
adolescent females aged 12 to 19 years.
2. Materials and Methods
A pilot cross-sectional study was conducted for a period of
one month (August-September 2013) at Balaji Hospital, Vel-
lore, Tamil Nadu, India. The study participants enrolled con-
stituted patients visiting this hospital fromVellore district, an
urban setting, and other surrounding villages of Puliyank-
annu, Vanapadi, Lalapet, Chettithangal, and Vepoor, which
are rural settings. A convenient based samplingwas employed
and the sampling frame used was the Outpatient Department
of Balaji Hospital.The study participants enrolled constituted
patients visiting this hospital from Vellore city (an urban
setting) and other surrounding villages of Puliyankannu,
Vanapadi, Lalapet, Chettithangal, and Vepoor, which are
rural settings.The inclusion criteria of the study comprised of
adolescent girls of age between 12 and 19 years having com-
plaints of menstrual disorders and living in urban and rural
settings respectively for at least past one year. Further these
adolescent girls must have had attained menarche at least 2
years before their existing complaint of menstrual disorder
and were ready to provide informed consent. Individuals
not fulfilling the inclusion criteria or participating in other
clinical trials or had mental and physical challenges or
were not willing to participate in the study were excluded
from study. Equal numbers of urban (𝑛 = 63) and rural
(𝑛 = 63) participants were enrolled with a total of 126
participants. All participants were enrolled after obtaining
informed consent or assent to participate in the study. All
of the study participants were interviewed in a separate
place from the clinician’s office for maintaining participant’s
confidentiality. The study protocol was approved by the IRB
of the Foundation of Healthcare Technologies Society, New
Delhi (IRB#FHTS/025/2013). Formaintaining the anonymity
each participant was assigned unique identification codes.
2.1. Data Collection Tools. Information about the variables
was gathered by using set of semistructured questionnaires
and anthropometric assessmentwas done by usingmeasuring
tape, weighing scale, and standard height rod. Noninvasive
sonographic scanningwas done to identify polycystic ovaries.
Further biochemical examination was done for obtaining the
values of prolactin, testosterone, T
3
, T
4
, and TSH (thyroid
stimulating hormone). Each section of data collection tool is
summarized below.
(i) Sociodemographics. Information gathered included age
(years), educational status, family structure, occupation,mar-
ital status, parity, family income, andwork schedule [11]. Data
was also gathered on the family history of chronic diseases.
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(ii) Anthropometric Measures. Physical assessments involved
multiple measurements on several anthropometric variables
including (a) height (meters), (b) weight (kg), (c) waist
circumference (cm), and (d) hip circumference (cm). All
four variables were measured without footwear and with
participant wearing light clothing. Height was measured by
using higher standard rod and weight was measured using a
weighing scale. BMI of individual participant was calculated
by dividing weight (Kg) by height in square meter. Waist and
hip circumferences were measured by using an inch tape.
For waist measurement superior most part of hip bone was
palpated and then measurement tape was encircled around
the stomach just above this point and umbilicus anteriorly.
Participants were asked to stand in relaxing position during
the measurements. Hip circumference was measured by
encircling the inch tape in broadest part of hip of the partic-
ipants. Two readings of height, weight, waist circumference,
and hip circumference were measured and their mean was
considered as final value. Information regarding weight gain
in the past three months was self-reported.
(iii) Clinical History.The study participants’ current history of
having disease conditions including diabetes, hypertension,
dyslipidemia, anorexia, and hypothyroidism was gathered.
Complaints of leukocoria,Acanthosis nigricans (skin pigmen-
tation), and presence of acne were also self-reported.
(iv) Menstrual History. Several parameters assessed included
bleeding duration per cycle, intensity of flow, frequency of
cycle, menstrual disorders, and average interval between
two consecutive periods, recent weight gain, and monthly
regularity of flow [12]. Menstrual flow history was assessed
by obtaining self-reported frequency of bleeding duration per
cycle.The daily intensity of menstrual flow was characterized
on a 5-point scale ranging from slight to heavy. A history
of common menstrual disorders including oligomenorrhea,
amenorrhea, polymenorrhea, and dysmenorrhea was self-
reported.
(v) Hirsutism/Androgen Production. Hirsutism and androgen
production were assessed based on the Ferryman-Gallewey
model in which study participants selected their degree of
hair growth across nine key anatomical sites based on picto-
graphic representations [13]. The various anatomical sites
included the lips, chin, chest, upper abdomen, lower
abdomen, arms, thighs, upper back, and lower back. The
severity of the condition was assigned based on a 4-point
scale and individual scores for each anatomic site were allo-
cated. A maximum score of 32 points was possible. The level
of androgen production was classified into three categories
including normal, mild, and moderate to severe, based on
total scores. Normal androgen production was defined by
a total score less than 8 points, mild androgen production
by a total score ranging from 9 to 15 points, and moderate
to severe production by a total score greater than 15 points.
Hyperandrogenism (excessive androgen production) was
characterized by average scores exceeding 8 points across all
anatomic sites [13].
(vi) Physical Activity and Diet Assessment. Physical activity
was self-reported based on the type of activity (i.e., walking,
running, and playing football), intensity levels (minutes/
hours/days), and the length of time spent on each activity [14].
The study participants’ nature of workwas assessed by obtain-
ing information regarding the type of work, number of hours
spent per day, and level of vigorous activity performed. A 24-
hour dietary recall was conducted to assess the nutritional
status of the subject. Participants were required to report their
food consumption at various meal periods of the previous
day. The food intake of the study participants was classified
into various nutrition types based on the WHO (2001) food
scoring technique [15, 16].
(vii) Polycystic Ovary Assessment. The presence of polycystic
ovaries was confirmed using noninvasive, transabdominal
ultrasonographic scanning [17]. A 3.5MHz convex probe was
employed in this process. Diagnosis for polycystic ovaries was
considered positive if 12 or more follicles measuring 2 and
9mm were found with ovary size of more than 10 cm3 [2].
(viii) Biochemical Assessment. For biochemical assessment
venous blood sample was taken by trained staff in morning
between 8 am and 10 am in early phase of cycle. Serum
testosterone levels were obtained using the ELISA method
[18]. Prolactin, T
3
, T
4
, and TSH level were assessed to rule
out hyperprolactinemia and hypothyroidism.
(ix) Individuals with PCOS. Participants were evaluated for
PCOS on the basis of NIH Criteria, Rotterdam criteria,
and guidelines of Rotterdam Consensus on women health
aspect of PCOS. Final diagnosis of PCOS was made if all
three elements of Rotterdam criteria were present which
included presence of oligomenorrhea after two years of
menarche or primary amenorrhea at the age of 16 years, and
polycystic ovaries on ultrasound along with ovarian size of
more than 10 cm3 and hyperandrogenemia should be present.
Hirsutism score of more than 8 was considered positive for
hyperandrogenemia.
2.2. Statistical Analysis. Descriptive statistics were computed
for various continuous and categorical variables and were
reported as means, standard deviations, and percentage
distributions. 𝑇 statistics and chi-square statistics were used
to compare means and percentage distribution among con-
tinuous and categorical variables. Data were analyzed using
IBM SPSS statistical software version 22.
3. Results
3.1. Study Population Characteristics. The average age of the
adolescent girls was 16 years (SD = 2) that lived mostly in a
nuclear family structure (75%, 𝑛 = 95) and were unmarried
(100%, 𝑛 = 126) and 28% (𝑛 = 35) of them had highest
education up to some college. Average household income of
the participants was 135,103 INR (US$ 2252 approximately).
The average BMI of the participants was 21 Kg/m2 with 11%
(𝑛 = 13) being overweight to obese. Twenty-six percent
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Figure 1: It depicts the frequency of daily reported food items
consumed by the study participants.
(𝑛 = 33) of the study participants reported a recent weight
gain in the past 3 months. No history of chronic diseases was
reported among these study participants. However, family
history of diabetes mellitus and hypertension was reported
(9%, 𝑛 = 12).
3.2. Physical Activity and Dietary Pattern. Twenty-four per-
cent (𝑛 = 30) of the study participants were involved in
vigorous physical activity with 82% (𝑛 = 103) of them
spending less than 30 minutes every day on any kind of
physical activity. Majority of the participants are involved in
other physical activities that included walking (51%, 𝑛 = 64)
and cycling (8%, 𝑛 = 10).
Dietary intakes of cereals, fruits, vegetables, meat, egg,
milk and its products, and fat and sweet food products
were reported based on a 24-hour recall. Hundred percent
of the participants reported consumption of cereals, potato,
bread, and related food products during breakfast, lunch, and
dinner. Consumption of vegetables and fruits was highest in
dinner (99%; 𝑛 = 125) followed by lunch (84%; 𝑛 = 106).
More than half of the participants reported consumption of
milk or milk products in breakfast (51%; 𝑛 = 64) followed by
dinner (42%; 𝑛 = 53). Overall 67% (𝑛 = 84) of the adolescents
reported consuming fat and oil products in form of evening
snacks along with tea (83%; 𝑛 = 104). Meat, poultry, egg,
and their alternatives were reported to be consumed highest
during lunch time by 88% (𝑛 = 111) of the participants
(Figure 1).
The WHO food scoring technique was utilized in clas-
sifying the dietary intake of the various foods into four
different groups including risky (<3), fair (4–7), good (8-9),
and excellent (10) [15]. Eighty- nine percent (𝑛 = 112) of the
study participants were classified as having a fair score. None
of the participants received an excellent score (Figure 2).
3.3. Menstrual and Clinical History and Hirsutism. The aver-
age age at menarche was 12 (SD = 1) years. Oligomenorrhea
(28%; 𝑛 = 35) and irregular menses with weight gain (19%;
𝑛 = 24) were the common menstrual disorders. The bleeding
Total
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100
80
60
40
20
0
Risky (<3) Fair (4–7) Excellent (10)Good (8-9)
Figure 2: It depicts the food score categories among urban and rural
participants.
duration per cycle ranged from a minimum of 1-2 days to a
maximum of 10–15 days.The presence ofAcanthosis nigricans
(skin pigmentation) was self-reported by 23% (𝑛 = 36) of the
study participants and included sites such as thigh folds (13%,
𝑛 = 16) and nape of the neck (9%, 𝑛 = 12). The lips (92%;
𝑛 = 116) and chin (68%, 𝑛 = 86) were the common sites
for hair growth with 48% (𝑛 = 60) having excess androgen
production (hirsutism score of 9 and above).
3.4. Ultrasound and Blood Investigation. Sixty-three percent
(𝑛 = 76) of the study participants had a positive radiology test
reflecting presence of polycystic ovaries. Hundred percent
of the participants have not sought any kind of treatment
for polycystic ovaries. Average testosterone level of the
participants was 2.47 pg/mL (SD = 1.6) ranging from .33 to
6.56 pg/mL. Thirty percent (𝑛 = 38) of the participants had
above normal testosterone level. Participants average serum
prolactin level was 14.7 𝜇g/liter. Average values of T
3
, T
4
,
and TSH were 152 ng/dL (SD = 23), 9.3 𝜇g/dL SD = 5, and
2.8 𝜇U/mL, respectively (Table 1).
3.5. Characteristics of Study Participants in Urban and
Rural Settings. A similar number of study participants were
enrolled across urban (50%, 𝑛 = 63) and rural (50%, 𝑛 = 63)
settings. There was minimal difference between the age of
urban and rural participants. The proportion of participants
living in nuclear family was higher among urban participants
as compared to their rural counterparts (87% versus 63%;
𝑃 = .002) and it was statistically significant. Family size,
annual household income, and highest education level had
not shown any statistically significant difference among the
urban and rural participants. Thirty-three percent (𝑛 = 21)
of participants in rural settings had some college education
compared to their urban counterparts (22%, 𝑛 = 14). Study
participants in urban settings had a higher proportion of
underweight adolescents (19%, 𝑛 = 12), compared to those
in rural settings (11%, 𝑛 = 7). Average waist-hip ratio of rural
participants (M = .85; SD = .03) was higher in comparison
to urban participants (M = .84; SD = .05) and this difference
was found to be statistically significant (𝑃 = .03). Nearly half
(48%; 𝑛 = 30) of the study participants in the urban settings
reported a recent weight gain in the past threemonths, which
was significantly higher compared to those in rural settings
BioMed Research International 5
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(5%, 𝑛 = 3) (𝑃 < .0001). The average age at menarche for
all the adolescent girls was similar for both urban and rural
adolescents (mean = 12, SD = 1). Urban participants had a
higher bleeding duration per cycle (M = 5 days; SD = 4)
compared to their rural counterparts (M = 4 days; SD =
2) and this was statistically significant across both groups
(𝑃 = 0.02). Frequency of less than or equal to 9 menses
was higher among the urban participants in comparison to
rural participants (67% versus 19%; 𝑃 < .0001). Similarly
urban participants (40%; 𝑛 = 25) had higher proportion of
individuals with oligomenorrhea in comparison with rural
participants (16%; 𝑛 = 10). Complaints of leucorrhea (24%,
𝑛 = 15; 𝑃 = .015) and weight gain with irregular menses
(37%, 𝑛 = 23; 𝑃 < .0001) were also reported to be
higher in frequency among urban participants. The urban
study participants had a higher frequency of excess androgen
activity (57%, 𝑛 = 35; 𝑃 = .001), which was evidenced by a
higher occurrence of hair growth across several anatomical
sites including the lips (99%, 𝑛 = 62; 𝑃 = .03), upper
abdomen (72%, 𝑛 = 45; 𝑃 = .006), lower abdomen (60%,
𝑛 = 38; 𝑃 = .03), arms (75%, 𝑛 = 47; 𝑃 = .02), thighs
(81%, 𝑛 = 51; 𝑃 = .001), and lower back (65%, 𝑛 = 41; 𝑃 =
.01). Categorical distribution of hirsutism scores (𝑃 = .04)
and positive ultrasonographic results for polycystic ovaries
have shown statistically significant association with location
of the participants. There was no statistically significant
difference for serum testosterone level of the urban and
rural participants. Engaging in vigorous work activity was
significantly higher among rural study participants (38%,
𝑛 = 24), compared to those in urban settings (10%, 𝑛 =
6) (𝑃 < .0001). Frequency of good score on WHO food
scoring technique was higher among rural participants (8%,
𝑛 = 5) compared to the urban participants (3%, 𝑛 = 2).
The proportion of urban participants diagnosed with PCOS
was higher than their rural counterparts (25% versus 11%;
𝑃 = .03) (Table 1).
3.6. Association of Characteristics of Study Population with
NIH Criteria and Rotterdam Criteria (Any of the Two Ele-
ments) and Consensus on Women Health Aspect of PCOS
for Adolescents (Presence of All Three Elements) Suggestions.
Analysis was performed to see any statistical significant
association between the independent variables of the study
participants withNIH criteria, Rotterdam criteria, and guide-
lines of RotterdamConsensus for diagnosing PCOS. Twenty-
five percent (𝑛 = 31) of the study participants were identified
as having PCOS using the NIH criteria, compared to the 54%
(𝑛 = 68) that were identified as having PCOS using the Rot-
terdam criteria (any of the two elements present). Eighteen
percent of the participants were confirmed of having PCOS
by recent guidelines of Rotterdam Consensus for adolescent
diagnosis of PCOS (presence of all three elements). Majority
of the individuals with PCOS had an average age of 16 (SD =
2) (𝑃 = .02) years with an average age of menarche 12 years
(SD= 1). Results showed statistically significant association of
RotterdamConsensus (all three elements present) andweight
gain in past three months (𝑃 = .006) and vigorous physical
activity (𝑃 = .06) (Table 2).
4. Discussion
Adolescent phase of life brings multiple physiological, ana-
tomical, and psychological changes in the life of girls. Due
to familial, cultural, and societal restrictions most of the
adolescent girls are not able to share and get right advice for
menstrual related problems. PCOS is one of these conditions
which is of serious concern. We have conducted this pilot
studywith the objective to determine the difference in burden
of PCOS in urban and rural settings of India.
Results of the study have shown that 18% of participants
were diagnosed with PCOS. Proportion of PCOS was higher
in urban population in comparison to rural counterparts.
Previous studies have reported a prevalence of PCOS ranging
from 2.2 to 26% [19]. To the best of our knowledge, this is the
second studywhich has been done to elucidate the proportion
of polycystic ovarian syndrome among Indian adolescents.
However, this study goes further by characterizing the distri-
bution of the PCOS phenotypes and stratifying the propor-
tion of participants based on urban and rural populations.
The prior study reported a prevalence of 9.1% among 15–18-
year-old adolescent females in Anantapur, Andhra Pradesh
[4]. Average BMI of the study participants was similar to the
prior study. However, our study had also reported the history
of anorexia or bulimia (3%, 𝑛 = 4) as well as a family history
of diabetes mellitus (9%, 𝑛 = 11), hypertension (9%, 𝑛 = 12),
and hypothyroidism (9%, 𝑛 = 1). Previous studies in Italy,
Iran, and Japan had shown 4.3%, 14.6%, and 26.2%prevalence
of PCOS, respectively [19–21].
Involvement in vigorous work activity was significantly
higher among rural participants compared to urban ones.
Majority of the study participants 89% (𝑛 = 112) were
classified as having a fair score (4–7) based on their dietary
patterns and the distribution was similar among rural (89%,
𝑛 = 56) and urban study participants (89%, 56). Having a fair
score indicated that the participants needed some changes in
their dietary pattern.
Despite the younger age of onset reported for polycystic
ovarian syndrome, there is a scarcity of longitudinal studies
examining the prevalence among adolescents. A study done
in an urban Iranian population (𝑛 = 929) had a lower prev-
alence of excess androgen activity (22%, 𝑛 = 205), compared
to our population (48%, 𝑛 = 60) [18]. Another prior study
has shown 52.4% (𝑛 = 11) of the study participants having
polycystic ovaries and 45.5% (𝑛 = 5) reported oligomen-
orrhea [21]. In our study the proportion of participants
with polycystic ovaries and oligomenorrhea was 63% and
28%, respectively. None of the study participants was found
positive for polycystic ovaries.
A major strength of this study is the wide range of
adolescent population studied (12 to 19 years). However, the
sample size (𝑛 = 126) utilized was considerably smaller com-
pared to similar studies. Secondly it was a cross-sectional
study so temporal association could not be determined.
Further it was specialized hospital based study so its result
cannot be generalized with the population.The increased risk
of developing Type 2 diabetes as a result of polycystic ovarian
syndrome is of immense public health concern especially
in India, which has been tagged as the diabetic capital of
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the world [10]. The reported younger onset of this syndrome
[8] and the prevalence of associated risk factors such as
glucose intolerance [10] in the Indian population signify a
need for intensified efforts in early detection. The increased
proportion reported among urban adolescents compared
to their rural counterparts is of great concern. Further
studies should be conducted to elucidate the predominant
risk factors in urban adolescents and the possible protective
factors among rural adolescents in order to proffer preventive
measures.
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